BioConnections
  • Home page
    • Coronavirus 2019-nCoV
    • Antibiotic Resistance
  • CHROMagar
  • MBlo IVDR
  • CoVID-19 products
  • Gonogen
  • MICROBIOLOGICS
  • MICRONAUT Broth Microdilution
  • Sifin Antisera
  • Newsletter 1
  • Newsletter 2
  • Mycology
  • BD Glucan key role
  • contact
  • CORIS BIOCONCEPT
  • Coris ReSCape
  • Coris RESIST
  • ontact Bench Reagents
  • Bench Reagents
  • MBLo Contact Neg Controls

MICRONAUT-S MDR MRGN-Screening

Picture
Phenotypic detection of clinically relevant cephalosporinases and carbapenemases
In recent years there has been an increase in multi-drug resistance (MDR) amongst gram-negative pathogens. This has impacted both hospital and community acquired infections.

The MICRONAUT-S MDR MRGN Screening plate provides an extended spectrum of critically important back-up antibiotics and meropenem screening concentrations for an improved detection of OXA-48-like type D carbapenemases.
It also offers an extended spectrum of antibiotics by introduction of the novel antibiotic combinations ceftazidime-avibactam and ceftolozane-tazobactam. 
MIC plate for AST of multi-drug resistant gram-negative bacteria (MDR phenotype)
The MICRONAUT-S MDR MRGN Screening plate offers a range of features and benefits relating to the phenotypic detection of clinically relevant resistance mechanisms. 
  • Resistance determination of all relevant gram-negative bacteria (Enterobacteria, Aeromonas, non-fermenters) against antibiotics and antibiotics combinations in a standard microdilution procedure
  • ​AST against the novel antibiotic combinations ceftazidime-avibactam and ceftolozane-tazobactam
  • Phenotypical detection of MBL (metallo-ß-lactamases) by resistance determination against meropenem as a mono substance and in combination with the divalent cationic chelator EDTA
  • Phenotypical detection of KPC (Klebsiella pneumoniae carbapenemase) by resistance determination against meropenem as a mono substance and in combination with 3-Amino-Phenyl-Borate (3-APB)
  • Phenotypical detection of AMP-C (Aminopenicillin inactivating cephalosporinase) by the susceptibility testing with 3 extended spectrum cephalosporins and their combination with (3-APB)
  • Detection of OXA-48-like type D carbapenemases based on the determination of temocillin high-level resistance
  • Detection of low-level carbapenem resistance by introduction of meropenem screening concentrations
  • Analysis and interpretation after visual or automated reading according to EUCAST or CLSI standard

    How can we help?

Submit
Picture
Brindley Court, Victoria Business Park
Knypersley ST8 7PP
T: 01782 516 010 
E: welcome@bioconnections.co.uk
  • Home page
    • Coronavirus 2019-nCoV
    • Antibiotic Resistance
  • CHROMagar
  • MBlo IVDR
  • CoVID-19 products
  • Gonogen
  • MICROBIOLOGICS
  • MICRONAUT Broth Microdilution
  • Sifin Antisera
  • Newsletter 1
  • Newsletter 2
  • Mycology
  • BD Glucan key role
  • contact
  • CORIS BIOCONCEPT
  • Coris ReSCape
  • Coris RESIST
  • ontact Bench Reagents
  • Bench Reagents
  • MBLo Contact Neg Controls